938 related articles for article (PubMed ID: 30634483)
1. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
2. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies.
Jiang P; Chan KCA; Lo YMD
J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
Zeng H; He B; Yi C; Peng J
J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
[TBL] [Abstract][Full Text] [Related]
4. Identifying the tissues-of-origin of circulating cell-free DNAs is a promising way in noninvasive diagnostics.
Peng X; Li HD; Wu FX; Wang J
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32427285
[TBL] [Abstract][Full Text] [Related]
5. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
Luo H; Wei W; Ye Z; Zheng J; Xu RH
Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
[TBL] [Abstract][Full Text] [Related]
6. Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin.
Sun K; Jiang P; Cheng SH; Cheng THT; Wong J; Wong VWS; Ng SSM; Ma BBY; Leung TY; Chan SL; Mok TSK; Lai PBS; Chan HLY; Sun H; Chan KCA; Chiu RWK; Lo YMD
Genome Res; 2019 Mar; 29(3):418-427. PubMed ID: 30808726
[TBL] [Abstract][Full Text] [Related]
7. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
8. Leveraging locus-specific epigenetic heterogeneity to improve the performance of blood-based DNA methylation biomarkers.
Miller BF; Pisanic Ii TR; Margolin G; Petrykowska HM; Athamanolap P; Goncearenco A; Osei-Tutu A; Annunziata CM; Wang TH; Elnitski L
Clin Epigenetics; 2020 Oct; 12(1):154. PubMed ID: 33081832
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic liquid biopsies: a novel putative biomarker in immunology and inflammation.
Fox-Fisher I; Shemer R; Dor Y
Trends Immunol; 2023 May; 44(5):356-364. PubMed ID: 37012121
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics and diagnostic applications of circulating cell-free DNA in colorectal cancer].
Barták BK; Márkus E; Kalmár A; Galamb O; Szigeti K; Nagy ZB; Zsigrai S; Tulassay Z; Dank M; Igaz P; Molnár B
Orv Hetil; 2019 Jul; 160(30):1167-1177. PubMed ID: 31327245
[TBL] [Abstract][Full Text] [Related]
11. Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy.
Tomasetti M; Amati M; Neuzil J; Santarelli L
Lung Cancer; 2017 May; 107():65-72. PubMed ID: 27312601
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic analysis of cell-free DNA by fragmentomic profiling.
Zhou Q; Kang G; Jiang P; Qiao R; Lam WKJ; Yu SCY; Ma ML; Ji L; Cheng SH; Gai W; Peng W; Shang H; Chan RWY; Chan SL; Wong GLH; Hiraki LT; Volpi S; Wong VWS; Wong J; Chiu RWK; Chan KCA; Lo YMD
Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2209852119. PubMed ID: 36288287
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Methylation-Specific PCR: A Simple Method for Studying Epigenetic Modifications of Cell-Free DNA.
Sigalotti L; Covre A; Colizzi F; Fratta E
Methods Mol Biol; 2019; 1909():137-162. PubMed ID: 30580429
[TBL] [Abstract][Full Text] [Related]
14. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
15. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
[TBL] [Abstract][Full Text] [Related]
16. Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers' Discovery.
Brancaccio M; Natale F; Falco G; Angrisano T
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31877923
[TBL] [Abstract][Full Text] [Related]
17. Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA.
van der Pol Y; Mouliere F
Cancer Cell; 2019 Oct; 36(4):350-368. PubMed ID: 31614115
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation biomarkers discovered
Vrba L; Oshiro MM; Kim SS; Garland LL; Placencia C; Mahadevan D; Nelson MA; Futscher BW
Epigenetics; 2020 Apr; 15(4):419-430. PubMed ID: 31775567
[TBL] [Abstract][Full Text] [Related]
19. Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review.
Arzuaga-Mendez J; Prieto-Fernández E; Lopez-Lopez E; Martin-Guerrero I; García-Ruiz JC; García-Orad A
Crit Rev Oncol Hematol; 2019 Jul; 139():7-15. PubMed ID: 31112884
[TBL] [Abstract][Full Text] [Related]
20. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]